subject: UNII:3ZY6J6Z6EE

subject_name: Droxidopa

object_name: spinal cord injury


subject: UNII:3ZY6J6Z6EE

object_name: hypotension

tested_intervention: yes


subject: UNII:3ZY6J6Z6EE

object_name: Hypotension, CTCAE


subject: DRUGBANK:DB17471

object_name: hepatitis B


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UNII:N02W67RKJS

object_name: multiple sclerosis

tested_intervention: unsure


subject: UNII:P28BIW0UTB

subject_name: FODIPIR


subject: PUBCHEM.COMPOUND:76967443

subject_name: Mangafodipir


subject: UNII:129FW80TG4

subject_name: Mn-Dpdp


subject: UMLS:C0637607

subject_name: Teslascan


subject: MESH:D011868

subject_name: Radioisotopes

object_name: Childhood Breast Carcinoma


subject: MESH:D011868

object_name: breast carcinoma


subject: MESH:D011868

object_name: breast cancer


subject: PUBCHEM.COMPOUND:54677977

subject_name: Teriflunomide

object_name: tropical spastic paraparesis


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: anesthesia; functional


subject: CHEBI:45783

subject_name: Imatinib

object_name: malignant soft tissue neoplasm


subject: CHEBI:45783

object_name: sarcoma


subject: CHEBI:45783

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:45783

object_name: childhood malignant fibrous histiocytoma of bone


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109559

object_name: prostate cancer


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18

object_name: prostate neoplasm


subject: CHEBI:49140


subject: CHEBI:49140


subject: CHEBI:49140

object_name: metastatic prostate carcinoma


subject: CHEBI:49140


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: UMLS:C4266448


subject: UMLS:C4266448


subject: UMLS:C4266448


subject: UMLS:C4266448


subject: UNII:7RPW6SU9SC

object_name: Childhood Malignant Solid Neoplasm


subject: UNII:7RPW6SU9SC

object_name: Malignant Solid Neoplasm


subject: UNII:7RPW6SU9SC

object_name: lymphoma


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: neuroendocrine neoplasm


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UMLS:C3490678

object_name: triple-negative breast carcinoma


subject: UMLS:C3490678

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:8069

subject_name: Phenobarbital

object_name: neonatal abstinence syndrome


subject: CHEBI:3242

subject_name: butorphanol

object_name: Visceral Pain


subject: CHEBI:3242

object_name: liver neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: acute lymphoblastic leukemia


subject: UMLS:C0308803

subject_name: dexamethasone injection

object_name: Acute Hypoxemic Respiratory Failure


subject: UMLS:C0308803


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: Mycoses


subject: CHEBI:184693

subject_name: GRANISETRON

object_name: Prolonged QTc Interval, CTCAE


subject: CHEBI:184693

object_name: Prolonged QTc interval


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:74538

subject_name: Leu-Gly-Gly

object_name: allergic asthma


subject: UMLS:C0721277

subject_name: LGG brand of Dyphylline/Guaifenesin


subject: UMLS:C1832078

subject_name: LGG Lactobacillus rhamnosus GG


subject: CHEBI:3077

subject_name: Betamethasone

object_name: lichen planus, oral


subject: GTOPDB:11592

subject_name: evorpacept

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:11592

object_name: Neck Carcinoma


subject: GTOPDB:11592

object_name: head and neck neoplasm


subject: GTOPDB:11592

object_name: head and neck cancer


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: CHEMBL.COMPOUND:CHEMBL4297880


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UMLS:C4329513


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Metastatic urothelial carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095458

subject_name: REZPEGALDESLEUKIN

object_name: alopecia areata


subject: CHEMBL.COMPOUND:CHEMBL5095458

object_name: alopecia


subject: UMLS:C5707940

subject_name: Rezpegaldesleukin


subject: UMLS:C5707940


subject: UMLS:C3177398

subject_name: DLBS 1033

object_name: benign paroxysmal positional vertigo


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Vaginal delivery (finding)


subject: CHEBI:4466

object_name: previous vaginal delivery (history)


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: UMLS:C1530677

object_name: liver carcinoma


subject: UMLS:C2987342


subject: CHEBI:64312

subject_name: Memantine

object_name: multiple sclerosis


subject: CHEBI:119915

object_name: Hip dysplasia


subject: CHEBI:119915

object_name: Hip Dysplasia


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:8884

subject_name: Rocuronium


subject: CHEBI:8884


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: MESH:D013607

subject_name: Tablets

object_name: opiate dependence


subject: UMLS:C0591786

subject_name: Mifegyne

object_name: uterine fibroid


subject: CHEBI:151315

subject_name: Heparin

object_name: atrial fibrillation


subject: CHEBI:151315

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:151315

object_name: Atrial Fibrillation, CTCAE


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: UNII:PUE0TO3XDR


subject: CHEBI:145431

subject_name: Indisulam

object_name: Embolism, Tumor


subject: CHEBI:145431

object_name: Neoplasm Metastasis


subject: CHEBI:145431

object_name: Metastatic Lesion


subject: CHEBI:145431

object_name: breast neoplasm


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: UMLS:C0879271


subject: RXCUI:1942744

subject_name: Vyxeos

object_name: leukemia


subject: RXCUI:1942744

object_name: childhood leukemia


subject: GTOPDB:4897

subject_name: ciliary neurotrophic factor

object_name: Idiopathic macular telangiectasia type 2


subject: CHEMBL.COMPOUND:CHEMBL4298063

subject_name: CILIARY NEUROTROPHIC FACTOR


subject: CHEBI:5959

subject_name: Irbesartan

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:5959

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:5959

object_name: morbid obesity


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Metastatic ocular melanoma


subject: CHEBI:231679

object_name: Metastatic Mucosal Melanoma


subject: CHEBI:231679

object_name: Melanoma of Unknown Primary


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: UNII:DPT0O3T46P


subject: UMLS:C3640096

object_name: Ascites


subject: UMLS:C3640096

object_name: Ascites, CTCAE


subject: UMLS:C3640096

object_name: ovarian cancer


subject: UMLS:C3640096

object_name: ovarian neoplasm


subject: UMLS:C3640096

object_name: ovarian carcinoma


subject: UMLS:C3640096

object_name: digestive system cancer


subject: UMLS:C3640096

object_name: digestive system neoplasm


subject: UMLS:C3640096

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:231679

object_name: Recurrent Salivary Gland Cancer


subject: CHEBI:231679

object_name: minor salivary gland carcinoma


subject: CHEBI:231679

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231679

object_name: Stage IVA Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231679

object_name: Stage IVC Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231679

object_name: Stage IVB Major Salivary Gland Cancer AJCC v7


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C4688343

object_name: non-small cell lung carcinoma


subject: CHEBI:68534

subject_name: Enzalutamide


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: CHEBI:45716

subject_name: Vorinostat

object_name: mantle cell lymphoma


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Metastasis


subject: CHEBI:70839

object_name: Metastatic Lesion


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Subarachnoid Hemorrhage, Spontaneous


subject: UMLS:C5401612

subject_name: Recombinant human plasma gelsolin

object_name: acute respiratory distress syndrome


subject: UMLS:C5401612

object_name: adult acute respiratory distress syndrome


subject: UMLS:C5401612

object_name: Infection


subject: UMLS:C5401612

object_name: Infection of musculoskeletal system


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: Fractured elbow


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UNII:19ORU63E06

object_name: cancer


subject: UNII:19ORU63E06

object_name: neoplasm


subject: UNII:19ORU63E06

object_name: carcinoma


subject: CHEBI:49960

subject_name: Vandetanib

object_name: malignant glioma


subject: PUBCHEM.COMPOUND:25101755

object_name: smallpox


subject: UNII:F925RR824R

subject_name: Tecovirimat


subject: CHEBI:52717

subject_name: Bortezomib

object_name: glomerulonephritis


subject: CHEBI:52717

object_name: IgA Nephropathy


subject: CHEBI:52717

object_name: focal segmental glomerulosclerosis


subject: CHEBI:52717

object_name: Focal Segmental Glomerulosclerosis, Not Otherwise Specified


subject: CHEBI:52717


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: melanoma


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:8382

subject_name: Prednisone

object_name: lichen planus, oral


subject: CHEBI:27958

subject_name: Cocaine

object_name: otorhinolaryngologic disease


subject: UMLS:C0919141

subject_name: Injection, somatropin, 1 mg administered

object_name: Congenital IGHD


subject: UMLS:C0919141

object_name: Reduced circulating growth hormone concentration


subject: UMLS:C0919141

object_name: isolated short stature


subject: UMLS:C0919141

object_name: Idiopathic short stature


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: paroxysmal nocturnal hemoglobinuria


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: MESH:C508870

subject_name: gemcitabine-oxaliplatin regimen

object_name: prostate carcinoma


subject: MESH:C508870

object_name: prostate cancer


subject: UMLS:C0006669

subject_name: Calcitonin Gene-Related Peptide

object_name: cluster headache syndrome


subject: CHEBI:65415

subject_name: Antroquinonol


subject: CHEMBL.COMPOUND:CHEMBL4297925

subject_name: EXEBACASE

object_name: Bacteremia caused by Staphylococcus aureus


subject: CHEMBL.COMPOUND:CHEMBL4297925

object_name: Staphylococcus aureus endocarditis


subject: UMLS:C5238170

subject_name: exebacase


subject: UMLS:C5238170


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: B-cell neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB

object_name: non-small cell lung carcinoma


subject: UMLS:C4329336


subject: UNII:T639ETH2JK


subject: UMLS:C5907974

subject_name: Adenosine A2A Receptor Antagonist JNJ-86974680


subject: CHEBI:231679

subject_name: ipilimumab

object_name: MGMT-Unmethylated Glioblastoma


subject: CHEBI:231679

object_name: Adult Gliosarcoma


subject: CHEBI:231679

object_name: gliosarcoma


subject: CHEBI:231679

object_name: Childhood Gliosarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:188074

object_name: malaria


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: transient ischemic attack


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Leber hereditary optic neuropathy


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:135552

subject_name: Prucalopride

object_name: Postoperative ileus


subject: CHEBI:135552

object_name: Postoperative Complications


subject: CHEBI:83766

subject_name: Olaparib

object_name: endometrial cancer


subject: CHEBI:83766

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Recurrent Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Localized Resectable Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Small bowel obstruction


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: carcinoma


subject: UMLS:C1134588

object_name: non-small cell lung carcinoma


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UMLS:C5200832

subject_name: Vistabex

object_name: Hemifacial Paralysis


subject: UMLS:C3491843

object_name: retinal disease


subject: UMLS:C3491843

object_name: Retinopathy


subject: UMLS:C3491843

object_name: Retinopathy, CTCAE


subject: UMLS:C3491843

object_name: genetic disease


subject: UMLS:C0378942

object_name: multiple sclerosis


subject: UMLS:C0378942

object_name: relapsing-remitting multiple sclerosis


subject: PUBCHEM.COMPOUND:66586232

object_name: Infection


subject: PUBCHEM.COMPOUND:66586232

object_name: infectious disease


subject: PUBCHEM.COMPOUND:66586232

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:66586232

object_name: chlorhexidine allergy


subject: PUBCHEM.COMPOUND:66586232

object_name: exanthem


subject: PUBCHEM.COMPOUND:66586232

object_name: Eruptions


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: CHEBI:3614


subject: CHEBI:6456

subject_name: Lidocaine

object_name: complications; spinal puncture


subject: UNII:MH5DMF9JKY

subject_name: Emavusertib

object_name: Unresectable Pancreatic Ductal Adenocarcinoma


subject: UNII:MH5DMF9JKY

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UNII:MH5DMF9JKY

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:MH5DMF9JKY

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: PUBCHEM.COMPOUND:118224238


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C1517701

subject_name: labetuzumab

object_name: pancreatic neoplasm


subject: GTOPDB:8251


subject: UNII:EFE6X5M3UY


subject: CHEBI:149534


subject: CHEBI:149534


subject: CHEBI:149534


subject: UMLS:C5207956

subject_name: PRONTOSAN


subject: UMLS:C5207956


subject: UMLS:C5207956


subject: PUBCHEM.COMPOUND:2269

object_name: pneumonia


subject: PUBCHEM.COMPOUND:2269

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:48923

subject_name: erythromycin


subject: CHEBI:48923


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: MESH:D000097909

subject_name: Second Generation Cephalosporins


subject: MESH:D000097909


subject: CHEBI:91529

object_name: Low back pain


subject: PUBCHEM.COMPOUND:287691

subject_name: Thiocolchicoside


subject: CHEBI:6128

subject_name: Ketoprofen


subject: UMLS:C0031610

subject_name: Phosphatidic Acid

object_name: sarcopenia


subject: CHEBI:16337

subject_name: Phosphatidate


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Adult Type Ovarian Granulosa Cell Tumor


subject: PUBCHEM.COMPOUND:121489720

object_name: maligant granulosa cell tumor of ovary


subject: CHEBI:4953

subject_name: Exemestane


subject: CHEBI:4953


subject: CHEBI:6427

subject_name: Leuprolide


subject: CHEBI:6427


subject: GTOPDB:9864

subject_name: tregalizumab

object_name: allergic asthma


subject: GTOPDB:9864

object_name: Dust mite allergy


subject: UNII:43D26MK176


subject: UNII:43D26MK176


subject: UMLS:C4519743


subject: UMLS:C4519743


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Pregnant


subject: CHEBI:149509

object_name: mild neurocognitive disorder


subject: CHEBI:149509

object_name: mild cognitive impairment


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: PUBCHEM.COMPOUND:16129681

subject_name: Ghrih-A

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:53481605

subject_name: Somatostatin


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Sedation


subject: CHEBI:6456

object_name: Sedated


subject: CHEBI:93775

subject_name: Amethopterin

object_name: acute graft versus host disease


subject: CHEBI:50681


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:53498

subject_name: triacetylcellulose


subject: UMLS:C2962221

subject_name: TAC


subject: UNII:105J35OE21

subject_name: Aducanumab


subject: UNII:105J35OE21


subject: UNII:105J35OE21

object_name: Alzheimer disease type 1


subject: UNII:12PYH0FTU9

subject_name: Lecanemab


subject: UNII:12PYH0FTU9


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: Abdominal wall defect


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:3298

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:3298

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:3298

object_name: Depression, CTCAE


subject: UMLS:C1565135

subject_name: Ethyl-EPA


subject: UMLS:C1565135


subject: UMLS:C1565135


subject: UMLS:C1565135


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:84883


subject: CHEBI:74857

subject_name: Thr-Glu

object_name: hypogonadism


subject: CHEBI:30452

subject_name: tellurium atom


subject: PR:000003640

subject_name: acyl-coenzyme A thioesterase 8


subject: UMLS:C3899997

subject_name: Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine

object_name: lymphoplasmacytic lymphoma


subject: UMLS:C3899997

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:48131

subject_name: Azelaic acid

object_name: acne


subject: UMLS:C5227659

object_name: type 2 diabetes mellitus


subject: UMLS:C5227659

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C5227659

object_name: metabolic syndrome X


subject: CHEBI:28358

subject_name: rac-lactic acid

object_name: alopecia areata


subject: CHEBI:28358

object_name: alopecia


subject: CHEBI:42111

subject_name: D-Lactic acid


subject: CHEBI:42111


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: CHEBI:78320

subject_name: Lactic acid


subject: CHEBI:78320


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: PUBCHEM.COMPOUND:633097


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9667


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:78432

subject_name: Ceritinib

object_name: Childhood Neuroblastoma


subject: CHEBI:78432

object_name: neuroblastoma


subject: CHEBI:78432

object_name: cancer


subject: CHEBI:78432

object_name: neoplasm


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Femur fracture


subject: PUBCHEM.COMPOUND:378119

subject_name: Panzem NCD

object_name: Metastatic Renal Cell Carcinoma


subject: PUBCHEM.COMPOUND:378119

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C1831866


subject: UMLS:C1831866


subject: CHEBI:95082

subject_name: Molibresib


subject: UMLS:C4317349

subject_name: Bet inhibitor gsk525762


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Disseminated Malignant Neoplasm


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:176724

subject_name: Etiracetam


subject: CHEBI:176724


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: rhinitis


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:60654

subject_name: valproate

object_name: spinal muscular atrophy


subject: CHEBI:60654

object_name: proximal spinal muscular atrophy


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:16347


subject: UMLS:C4080036

object_name: asthma


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: hepatic encephalopathy


subject: CHEBI:37943

subject_name: colistin


subject: UMLS:C4283960

subject_name: Wu-ling-San

object_name: lymphedema


subject: UMLS:C4283960

object_name: Lymphedema, CTCAE


subject: UMLS:C4283960

object_name: Childhood Breast Carcinoma


subject: UMLS:C4283960

object_name: breast carcinoma


subject: UMLS:C4283960

object_name: breast cancer


subject: KEGG.COMPOUND:C00816

subject_name: Collagenase

object_name: adhesion of flexor tendon of hand


subject: UNII:9X7O8V25IT

subject_name: collagenase


subject: UMLS:C5544289


subject: UMLS:C3864947

subject_name: Gardasil 9

object_name: human papilloma virus infection


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: pemphigus


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: cystic fibrosis


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:84040

object_name: age-related macular degeneration


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: UMLS:C4688638

object_name: Advanced cancer


subject: UNII:J8435V445B

subject_name: Alicaforsen

object_name: Crohn disease


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Childhood Neuroblastoma


subject: CHEBI:72317

object_name: neuroblastoma


subject: CHEBI:231355

subject_name: Tasquinimod

object_name: plasma cell myeloma


subject: CHEBI:6047

subject_name: isoprothiolane

object_name: Depressed mood


subject: PR:000016675


subject: CHEBI:18067

subject_name: Phylloquinone

object_name: Postmenopausal osteopenia


subject: CHEBI:18067

object_name: postmenopausal osteoporosis


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:43805

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C3896875

object_name: ovarian cancer


subject: UMLS:C3896875

object_name: ovarian neoplasm


subject: UMLS:C3896875

object_name: ovarian carcinoma


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: Pregnant


subject: UMLS:C0060061

subject_name: Fansidar


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: malignant germ cell tumor


subject: UNII:7XL5ISS668

object_name: Germ Cell Cancer


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: PUBCHEM.COMPOUND:87067662

subject_name: Acetylcystine

object_name: common cold


subject: CHEBI:4875

subject_name: Etanercept

object_name: B-cell chronic lymphocytic leukemia


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: CHEBI:41423

subject_name: Celecoxib

object_name: non-small cell lung carcinoma


subject: PR:000001127

subject_name: cell surface glycoprotein MUC18

object_name: malignant soft tissue neoplasm


subject: PR:000001127

object_name: sarcoma


subject: PR:000001127

object_name: Ewing sarcoma


subject: PR:000001127

object_name: bone sarcoma


subject: PR:000001127

object_name: Kaposi Sarcoma


subject: PR:000001127

object_name: synovial sarcoma


subject: PR:000001127

object_name: lymphoma


subject: PR:000001127

object_name: Childhood Soft Tissue Sarcoma


subject: PR:000001127

object_name: Adult Soft Tissue Sarcoma


subject: PR:000001127

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: PR:000001127

object_name: soft tissue sarcoma


subject: PR:000001127

object_name: Metastatic sarcoma


subject: PR:000001127

object_name: Sarcoma of bone and connective tissue


subject: UMLS:C4042779

object_name: asthma


subject: UMLS:C5139926


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Extra-osseous Ewing's sarcoma non-metastatic


subject: CHEBI:4026

object_name: peripheral primitive neuroectodermal tumor of soft tissues


subject: CHEBI:4026

object_name: peripheral primitive neuroectodermal tumor of bone


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: ovarian cancer


subject: CHEBI:63584

object_name: ovarian neoplasm


subject: CHEBI:63584

object_name: ovarian carcinoma


subject: CHEBI:83766

subject_name: Olaparib

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:68855

subject_name: Ioflupane I-123

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:68855

object_name: clear cell renal carcinoma


subject: CHEBI:73503

subject_name: Glu-Asp

object_name: inflammatory bowel disease


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Liver Fibrosis


subject: CHEBI:473990

subject_name: Entecavir


subject: GTOPDB:11182

subject_name: concizumab

object_name: Hereditary factor VIII deficiency disease without inhibitor


subject: GTOPDB:11182

object_name: Hereditary factor IX deficiency disease without inhibitor


subject: CHEMBL.COMPOUND:CHEMBL4297730

subject_name: CONCIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297730


subject: UMLS:C3494079


subject: UMLS:C3494079


subject: CHEBI:50378

subject_name: Nitisinone

object_name: tyrosinemia type I


subject: CHEBI:229764

subject_name: Selinexor

object_name: leiomyosarcoma


subject: CHEBI:229764

object_name: Childhood Leiomyosarcoma


subject: CHEBI:229764

object_name: Adult Leiomyosarcoma


subject: CHEBI:229764

object_name: endometrioid stromal sarcoma


subject: CHEBI:229764

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:229764

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:229764

object_name: sarcoma


subject: CHEBI:229764

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:229764

object_name: soft tissue sarcoma


subject: CHEBI:229764

object_name: malignant peripheral nerve sheath tumor


subject: UMLS:C4721943

object_name: triple-negative breast carcinoma


subject: UMLS:C1882413

subject_name: Poly(ADP-ribose) Polymerase Inhibitors


subject: UMLS:C4019076

subject_name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


subject: CHEBI:61599

object_name: Prostate cancer recurrent


subject: CHEBI:61599

object_name: prostate adenocarcinoma


subject: UMLS:C0599934

subject_name: Vaccines, Peptide


subject: UMLS:C0599934


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: DRUGBANK:DB17475


subject: CHEBI:9434

subject_name: Telmisartan

object_name: abdominal aortic aneurysm


subject: CHEBI:9434

object_name: aortic aneurysm, familial abdominal, 1


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Hemorrhage


subject: GTOPDB:11278

subject_name: bemarituzumab


subject: UNII:RJW23BQ0KW


subject: UMLS:C3896858


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:75179

subject_name: Trifluridine


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:70839

subject_name: Dasatinib

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Mesothelioma


subject: CHEBI:231598

object_name: mesothelial neoplasm


subject: GTOPDB:13316

subject_name: maridebart cafraglutide

object_name: obstructive sleep apnea syndrome


subject: UNII:Z24U3U73HN

subject_name: MARIDEBART CAFRAGLUTIDE


subject: UMLS:C5855458

subject_name: Maridebart Cafraglutide


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Inflammation


subject: UMLS:C5556351

object_name: Stomach cancer


subject: UMLS:C5556351

object_name: gastric cancer


subject: UMLS:C5556781

subject_name: Anti-PD-1/Anti-TIM-3 Bispecific Antibody AZD7789


subject: UMLS:C5556781


subject: UNII:YSL2GUT2Q8

subject_name: RILVEGOSTOMIG


subject: UNII:YSL2GUT2Q8


subject: UMLS:C5706461

subject_name: Rilvegostomig


subject: UMLS:C5706461


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG


subject: CHEMBL.COMPOUND:CHEMBL5095362


subject: UMLS:C5417881

subject_name: Volrustomig


subject: UMLS:C5417881


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Premenstrual Dysphoric Disorder


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: congenital heart disease


subject: UNII:981TME683S

subject_name: Ropeginterferon alfa-2b

object_name: myeloproliferative neoplasm


subject: UNII:981TME683S

object_name: Malignant myeloproliferative neoplasm


subject: UNII:981TME683S

object_name: myelofibrosis


subject: UMLS:C3827091


subject: UMLS:C3827091


subject: UMLS:C3827091


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: dentin sensitivity


subject: UNII:WGB3V7X9VT

object_name: mixed connective tissue disease


subject: UNII:WGB3V7X9VT

object_name: Sicca Syndrome


subject: CHEBI:192761

subject_name: Iron sucrose

object_name: Complication of peritoneal dialysis


subject: CHEBI:192761

object_name: hyperphosphatemia


subject: CHEBI:192761

object_name: Serum phosphate concentrations above normal (finding)


subject: CHEBI:192761

object_name: Hyperphosphatemia, CTCAE


subject: CHEBI:192761

object_name: Hypoalbuminemia, CTCAE


subject: CHEBI:192761

object_name: Serum albumin level decreased below normal (finding)


subject: CHEBI:192761

object_name: Hypoalbuminemia


subject: MESH:C487655

subject_name: OPT 80

object_name: diarrhea


subject: MESH:C487655

object_name: rectal discharge diarrhea (physical finding)


subject: MESH:C487655

object_name: Diarrhea, CTCAE


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Malignant Solid Neoplasm


subject: UNII:DPT0O3T46P

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Breast Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage III Ovarian Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Breast Carcinoma


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: POLD1 Gene Mutation


subject: UNII:DPT0O3T46P

object_name: POLE Gene Mutation


subject: UMLS:C0599685

subject_name: Anti-Retroviral Agents

object_name: aneurysm


subject: UMLS:C0599685

object_name: cardiovascular disorder


subject: UMLS:C0599685

object_name: HIV-1 infection


subject: UMLS:C0599685

object_name: Adverse reaction to antiviral drugs


subject: UMLS:C0599685

object_name: HIV-Associated Lipodystrophy Syndrome


subject: UMLS:C0599685

object_name: Abnormal adipose tissue morphology


subject: UMLS:C0599685

object_name: Body fat disorder


subject: UMLS:C0599685

object_name: Weight Change


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir


subject: PUBCHEM.COMPOUND:57414794


subject: PUBCHEM.COMPOUND:57414794


subject: PUBCHEM.COMPOUND:57414794


subject: PUBCHEM.COMPOUND:57414794


subject: PUBCHEM.COMPOUND:57414794


subject: PUBCHEM.COMPOUND:57414794


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: otitis media


subject: CHEBI:100241

object_name: infectious otitis media


subject: CHEBI:100241

object_name: Otitis Media, CTCAE


subject: PUBCHEM.COMPOUND:133090

subject_name: Talnetant

object_name: schizophrenia


subject: UNII:CZ3T9T146K


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:145371

object_name: breast adenocarcinoma


subject: UNII:DPT0O3T46P


subject: UMLS:C2077029

subject_name: inhaled budesonide

object_name: Eosinophilic bronchitis


subject: UMLS:C0111046

subject_name: Creon

object_name: chronic pancreatitis


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Locally Advanced Urothelial Carcinoma


subject: UNII:DLE8519RWM

object_name: Metastatic urothelial carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UNII:DPT0O3T46P


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan


subject: GTOPDB:13791


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UNII:3DV5TD1VL3


subject: UMLS:C5237963

subject_name: ADC SKB264


subject: UMLS:C5237963


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox

object_name: metastatic colorectal cancer


subject: UMLS:C2917382

subject_name: Erythropoiesis-stimulating Agent [EPC]

object_name: anemia


subject: UMLS:C2917382

object_name: Anemia, CTCAE


subject: UMLS:C2917382

object_name: end stage renal failure


subject: UMLS:C2917382

object_name: Chronic uremia


subject: PR:000007559


subject: PR:000007559


subject: PR:000007559


subject: PR:000007559


subject: PUBCHEM.COMPOUND:11963629

subject_name: ferryl iron


subject: PUBCHEM.COMPOUND:11963629


subject: MESH:C116580

subject_name: fructooligosaccharide

object_name: developmental and epileptic encephalopathy, 2


subject: MESH:C116580

object_name: CDKL5 disorder


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin


subject: PUBCHEM.COMPOUND:18772499


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: CHEBI:64103

subject_name: sodium butyrate


subject: CHEBI:64103


subject: UMLS:C0142812

subject_name: Sodium Butyrate


subject: UMLS:C0142812


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:30772


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Diverticular Diseases


subject: PUBCHEM.COMPOUND:46783403

object_name: Diverticulosis


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Congenital hallux valgus


subject: CHEBI:6456

object_name: Acquired hallux valgus


subject: CHEBI:6456

object_name: Hallux valgus


subject: UNII:OJE5810C4F

subject_name: Taxoprexin

object_name: renal carcinoma


subject: UNII:OJE5810C4F

object_name: kidney neoplasm


subject: UNII:OJE5810C4F

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:156151242

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:156151242

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:156151242

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:156151242

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:156151242

object_name: malignant peripheral nerve sheath tumor


subject: PUBCHEM.COMPOUND:156151242

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:156151242

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:156151242

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:156151242

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:156151242

object_name: malignant mesothelioma


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: vascular dementia


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: pulmonary edema of mountaineers, susceptibility to


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:553827

subject_name: Bambuterol


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Sedation


subject: CHEBI:17045

object_name: Sedated


subject: CHEBI:17045

object_name: glaucoma


subject: CHEBI:17045

object_name: Glaucoma, CTCAE


subject: UMLS:C3827165

subject_name: Anti-CD27L Antibody-Drug Conjugate AMG 172

object_name: clear cell renal carcinoma


subject: UMLS:C3827165

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3827165

object_name: renal cell adenocarcinoma


subject: UMLS:C3827165

object_name: renal cell carcinoma


subject: CHEBI:149601

subject_name: Bempedoic acid

object_name: type 2 diabetes mellitus


subject: CHEBI:49040

subject_name: Ezetimibe


subject: PUBCHEM.COMPOUND:71300864

object_name: Heart failure with normal ejection fraction


subject: UMLS:C2933615

subject_name: LCZ 696


subject: CHEBI:94366

subject_name: itraconazole

object_name: tinea capitis


subject: UMLS:C4527304

subject_name: Carbon C 11 Glutamine

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4527304

object_name: Neck Carcinoma


subject: UMLS:C4527304

object_name: head and neck neoplasm


subject: UMLS:C4527304

object_name: head and neck cancer


subject: UNII:92T1Y5X038

subject_name: Florilglutamic acid F-18


subject: UNII:92T1Y5X038


subject: UNII:92T1Y5X038


subject: UNII:92T1Y5X038


subject: UMLS:C4053691


subject: UMLS:C4053691


subject: UMLS:C4053691


subject: UMLS:C4053691


subject: UMLS:C5139812


subject: UMLS:C5139812


subject: UMLS:C5139812


subject: UMLS:C5139812


subject: CHEBI:28061

subject_name: galactose

object_name: diabetic macular edema


subject: CHEBI:42905

subject_name: L-Galactose


subject: KEGG.COMPOUND:C01582

subject_name: Galactose


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Neoplasm of uncertain or unknown behavior of kidney


subject: CHEBI:61057

object_name: kidney benign neoplasm


subject: CHEBI:61057

object_name: Kidney problem


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:16796

subject_name: Melatonin

object_name: septic shock


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:28939

object_name: Increased reactive oxygen species production


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: PUBCHEM.COMPOUND:164593978

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:164593978

object_name: acute myeloid leukemia


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: bariatric surgery candidate


subject: UMLS:C0770246

object_name: Intolerance to protein


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: intrahepatic cholangiocarcinoma


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: colon carcinoma


subject: GTOPDB:11376

object_name: colorectal cancer


subject: GTOPDB:11376

object_name: colon cancer


subject: GTOPDB:11376

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: GTOPDB:11376

object_name: oropharyngeal carcinoma


subject: GTOPDB:11376

object_name: oropharynx cancer


subject: GTOPDB:11376

object_name: vaginal cancer


subject: GTOPDB:11376

object_name: vaginal carcinoma


subject: GTOPDB:11376

object_name: cervical cancer


subject: GTOPDB:11376

object_name: cervical carcinoma


subject: GTOPDB:11376

object_name: anus cancer


subject: GTOPDB:11376

object_name: anal carcinoma


subject: GTOPDB:11376

object_name: vulva cancer


subject: GTOPDB:11376

object_name: vulva carcinoma


subject: GTOPDB:11376

object_name: Adult Penile Carcinoma


subject: GTOPDB:11376

object_name: penis carcinoma


subject: GTOPDB:11376

object_name: penile cancer


subject: GTOPDB:11376

object_name: Cancer of Neck


subject: GTOPDB:11376

object_name: human papilloma virus infection


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: colon cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: oropharyngeal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: oropharynx cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: vaginal cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: vaginal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: anus cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: anal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: vulva cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: vulva carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: Adult Penile Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: penis carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: penile cancer


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: Cancer of Neck


subject: CHEMBL.COMPOUND:CHEMBL4298024

object_name: human papilloma virus infection


subject: UMLS:C4086994

object_name: colon carcinoma


subject: UMLS:C4086994

object_name: colorectal cancer


subject: UMLS:C4086994

object_name: colon cancer


subject: UMLS:C4086994

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: UMLS:C4086994

object_name: oropharyngeal carcinoma


subject: UMLS:C4086994

object_name: oropharynx cancer


subject: UMLS:C4086994

object_name: vaginal cancer


subject: UMLS:C4086994

object_name: vaginal carcinoma


subject: UMLS:C4086994

object_name: cervical cancer


subject: UMLS:C4086994

object_name: cervical carcinoma


subject: UMLS:C4086994

object_name: anus cancer


subject: UMLS:C4086994

object_name: anal carcinoma


subject: UMLS:C4086994

object_name: vulva cancer


subject: UMLS:C4086994

object_name: vulva carcinoma


subject: UMLS:C4086994

object_name: Adult Penile Carcinoma


subject: UMLS:C4086994

object_name: penis carcinoma


subject: UMLS:C4086994

object_name: penile cancer


subject: UMLS:C4086994

object_name: Cancer of Neck


subject: UMLS:C4086994

object_name: human papilloma virus infection


subject: CHEBI:132082

subject_name: Entinostat

object_name: colon carcinoma


subject: CHEBI:132082

object_name: colon cancer


subject: CHEBI:132082

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:132082

object_name: oropharyngeal carcinoma


subject: CHEBI:132082

object_name: oropharynx cancer


subject: CHEBI:132082

object_name: vaginal cancer


subject: CHEBI:132082

object_name: vaginal carcinoma


subject: CHEBI:132082

object_name: cervical cancer


subject: CHEBI:132082

object_name: cervical carcinoma


subject: CHEBI:132082

object_name: anus cancer


subject: CHEBI:132082

object_name: anal carcinoma


subject: CHEBI:132082

object_name: vulva cancer


subject: CHEBI:132082

object_name: vulva carcinoma


subject: CHEBI:132082

object_name: Adult Penile Carcinoma


subject: CHEBI:132082

object_name: penis carcinoma


subject: CHEBI:132082

object_name: penile cancer


subject: CHEBI:132082

object_name: Cancer of Neck


subject: CHEBI:132082

object_name: human papilloma virus infection


subject: UMLS:C5238316

subject_name: KRAS G12C Inhibitor JNJ-74699157

object_name: non-small cell lung carcinoma


subject: UMLS:C5238316

object_name: colorectal cancer


subject: UMLS:C5238316

object_name: colorectal carcinoma


subject: UMLS:C5238316

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5238316

object_name: neoplasm


subject: CHEBI:42944

subject_name: Galantamine

object_name: Parkinson disease


subject: UNII:2BT4C47RUI

subject_name: Necitumumab


subject: CHEBI:74705

subject_name: Met-Leu

object_name: anxiety


subject: CHEBI:74705

object_name: anxiety disorder


subject: CHEBI:74705

object_name: Anxiety symptoms


subject: CHEBI:74705

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:74705

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:74705

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:74705

object_name: Procedural anxiety


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C4055461

subject_name: Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein

object_name: mantle cell lymphoma


subject: UMLS:C4055461

object_name: CD20-Positive Neoplastic Cells Present


subject: UMLS:C4055461

object_name: diffuse large B-cell lymphoma


subject: UMLS:C4055461

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C4055461

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C4055461

object_name: B-cell lymphoma recurrent


subject: UMLS:C4055461

object_name: Refractory Mature B-Cell Non-Hodgkin Lymphoma


subject: UMLS:C4055461

object_name: Indolent Non-Hodgkin Lymphoma


subject: UMLS:C4055461

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: UMLS:C4055461

object_name: Burkitt lymphoma


subject: UMLS:C4055461

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C4055461

object_name: Adult Burkitt Lymphoma


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: UMLS:C0492712

subject_name: AGENT, CLEARING


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: UMLS:C0492712


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:132967

subject_name: Elbasvir

object_name: kidney failure


subject: CHEBI:132967

object_name: Renal Failure, CTCAE


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR


subject: UNII:4O2AB118LA


subject: CHEBI:132975

subject_name: Grazoprevir


subject: CHEBI:132975


subject: CHEBI:75551


subject: CHEBI:75551


subject: CHEBI:84739

object_name: multidrug-resistant tuberculosis


subject: CHEBI:2637

subject_name: Amikacin


subject: UMLS:C0762592

object_name: prostate carcinoma


subject: UMLS:C0762592

object_name: prostate cancer


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91083


subject: CHEBI:70839

subject_name: Dasatinib

object_name: lung cancer


subject: CHEBI:70839

object_name: lung neoplasm


subject: CHEBI:70839

object_name: lung carcinoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C2607231

subject_name: ABT 335

object_name: coronary artery disorder


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: tumor of uterus


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:64816

object_name: leiomyosarcoma


subject: CHEBI:64816

object_name: Childhood Leiomyosarcoma


subject: CHEBI:64816

object_name: Adult Leiomyosarcoma


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:3441

subject_name: Carvedilol

object_name: cocaine abuse


subject: CHEBI:76358

object_name: Abnormal foot morphology


subject: UMLS:C5400891

object_name: chronic hepatitis C virus infection


subject: UMLS:C4043002

subject_name: peginterferon lambda-1a


subject: PUBCHEM.COMPOUND:9861622

subject_name: Ecopipam

object_name: Childhood-onset fluency disorder (stuttering)


subject: UMLS:C1958450

subject_name: Duac gel

object_name: acne


subject: PUBCHEM.COMPOUND:121268274

object_name: Ewing sarcoma


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:74947

object_name: stage IV pancreatic cancer


subject: CHEBI:74947

object_name: Chemotherapy-induced nausea and vomiting


subject: PUBCHEM.COMPOUND:2269

object_name: gastroparesis


subject: PUBCHEM.COMPOUND:2269

object_name: Gastroparesis, CTCAE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UMLS:C5554967

subject_name: Oxygen Carrier YQ23

object_name: Rest limb pain


subject: CHEBI:231614

subject_name: Nivolumab

object_name: encephalitis


subject: UMLS:C2346820


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:4026

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEBI:4026

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:4026

object_name: splenic marginal zone lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:41879

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:41879


subject: CHEBI:41879

object_name: MALT lymphoma


subject: CHEBI:41879


subject: CHEBI:31709

subject_name: Iohexol

object_name: colorectal cancer


subject: CHEBI:31709

object_name: colorectal carcinoma


subject: CHEBI:31709

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:66662059

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:66662059

object_name: Insulin resistance


subject: PUBCHEM.COMPOUND:66662059

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:66662059

object_name: obesity


subject: PUBCHEM.COMPOUND:66662059

object_name: Obesity, CTCAE


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine


subject: UMLS:C0032375

object_name: severe acute respiratory syndrome


subject: UMLS:C1328728

object_name: liver cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: kidney disorder


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: PUBCHEM.COMPOUND:71766360

subject_name: TINODASERTIB

object_name: metastatic colorectal cancer


subject: UNII:MND3WX2R7I


subject: UNII:0Y70779M1F

subject_name: Botulinum toxin type B

object_name: Drooling


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: rhegmatogenous retinal detachment


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Non-ST Elevation Myocardial Infarction


subject: CHEBI:37941

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C2267235

subject_name: Vitamin K Antagonist [EPC]

object_name: coronary artery disorder


subject: UMLS:C2267235

object_name: Angina pectoris


subject: UMLS:C2267235

object_name: angina unstable


subject: UMLS:C2267235

object_name: Non-ST Elevated Myocardial Infarction


subject: UMLS:C2267235


subject: UMLS:C2267235

object_name: ST-elevation myocardial infarction


subject: UMLS:C2267235


subject: UMLS:C3653316

subject_name: Vitamin K antagonists


subject: UMLS:C3653316


subject: UMLS:C3653316


subject: UMLS:C3653316


subject: UMLS:C3653316


subject: UMLS:C3653316


subject: UMLS:C3653316


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:68579


subject: CHEBI:70746

subject_name: Dabigatran etexilate


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70746


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:70752


subject: PUBCHEM.COMPOUND:162369732

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:162369732

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:162369732

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:162369732

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:162369732

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:162369732

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:162369732

object_name: colorectal carcinoma


subject: MESH:C000723088

subject_name: KRASG12D inhibitor MRTX1133


subject: MESH:C000723088


subject: MESH:C000723088


subject: MESH:C000723088


subject: MESH:C000723088


subject: MESH:C000723088


subject: MESH:C000723088


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: asthma


subject: CHEBI:77260

subject_name: Omeprazole


subject: PUBCHEM.COMPOUND:122197547

subject_name: VOXILAPREVIR

object_name: hepatitis C


subject: UMLS:C5392709

subject_name: Eleview

object_name: Post procedural complication


subject: UMLS:C5392709

object_name: Procedural haemorrhage


subject: UMLS:C5392709

object_name: Postpolypectomy syndrome


subject: PUBCHEM.COMPOUND:24846132

subject_name: Hetastarch


subject: PUBCHEM.COMPOUND:24846132


subject: PUBCHEM.COMPOUND:24846132


subject: DRUGBANK:DB09106

subject_name: hetastarch


subject: DRUGBANK:DB09106


subject: DRUGBANK:DB09106


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Cancer of Head


subject: CHEBI:114785

object_name: Cancer of Neck


subject: CHEBI:114785

object_name: laryngeal carcinoma


subject: CHEBI:114785

object_name: larynx cancer


subject: CHEBI:114785

object_name: pharynx cancer


subject: CHEBI:114785

object_name: carcinoma of pharynx


subject: CHEBI:114785

object_name: paranasal sinus neoplasm


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:41423


subject: CHEBI:45652

subject_name: Succinylcholine

object_name: Complication of ventilation therapy


subject: CHEBI:45652

object_name: Tumor of lung parenchyma


subject: CHEBI:45652

object_name: Atelectasis


subject: CHEBI:45652

object_name: Atelectasis, CTCAE


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Crohn disease


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: UMLS:C2932252

object_name: insomnia


subject: UMLS:C2932252

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C2932252

object_name: Insomnia, CTCAE 5.0


subject: UNII:961YV2O515

subject_name: Efgartigimod alfa

object_name: myasthenia gravis


subject: UNII:961YV2O515

object_name: Myasthenia Gravis, CTCAE


subject: UMLS:C1831941

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C1831941

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:YI437801BE

subject_name: Mogamulizumab


subject: UNII:YI437801BE


subject: CHEBI:6121

subject_name: Ketamine

object_name: Fractured rib


subject: CHEBI:6121

object_name: Multiple rib fractures


subject: CHEBI:6121

object_name: Injury of ribs


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:74061

subject_name: Ile-Arg

object_name: abdominal aortic aneurysm


subject: CHEBI:74061

object_name: aortic aneurysm, familial abdominal, 1


subject: CHEBI:49666

subject_name: iridium atom


subject: CHEBI:49666


subject: PR:000009064

subject_name: insulin receptor


subject: PR:000009064


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: myeloid leukemia


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: melanoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: non-small cell lung carcinoma


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UMLS:C5238977

subject_name: BNT 312


subject: UMLS:C5238977

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5238977


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863

object_name: Malignant Solid Neoplasm


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: type 2 diabetes mellitus


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: CHEBI:16374

subject_name: Menatetrenone


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Acne inversa


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: Urination Disorders


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: Neck Carcinoma


subject: UNII:W0ZE0NT8IF

object_name: head and neck neoplasm


subject: UNII:W0ZE0NT8IF

object_name: head and neck cancer


subject: UNII:W0ZE0NT8IF

object_name: laryngeal carcinoma


subject: UNII:W0ZE0NT8IF

object_name: larynx cancer


subject: UNII:W0ZE0NT8IF

object_name: head and neck squamous cell carcinoma


subject: UNII:W0ZE0NT8IF

object_name: pharynx cancer


subject: UNII:W0ZE0NT8IF

object_name: carcinoma of pharynx


subject: UNII:W0ZE0NT8IF

object_name: oral cavity carcinoma


subject: UNII:W0ZE0NT8IF

object_name: oral cavity cancer


subject: UNII:W0ZE0NT8IF

object_name: oropharyngeal carcinoma


subject: UNII:W0ZE0NT8IF

object_name: oropharynx cancer


subject: UNII:W0ZE0NT8IF

object_name: hypopharynx cancer


subject: UNII:W0ZE0NT8IF

object_name: oral cavity squamous cell carcinoma


subject: UNII:W0ZE0NT8IF

object_name: hypopharynx squamous cell carcinoma


subject: UNII:W0ZE0NT8IF

object_name: oropharynx squamous cell carcinoma


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Gastrointestinal hemorrhage


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C4683552

object_name: Endometrial carcinosarcoma


subject: UMLS:C4683552

object_name: endometrium adenocarcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: GTOPDB:12989

subject_name: toripalimab

object_name: bladder tumor


subject: GTOPDB:12989

object_name: urinary bladder carcinoma


subject: GTOPDB:12989

object_name: urinary bladder cancer


subject: GTOPDB:12989

object_name: childhood bladder carcinoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: PUBCHEM.COMPOUND:65405

subject_name: Maloprim

object_name: malaria


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: intracranial hypertension


subject: MESH:D012462

object_name: traumatic encephalopathy


subject: MESH:D012462

object_name: traumatic brain injury


subject: CHEBI:16899

subject_name: Mannitol


subject: CHEBI:16899


subject: CHEBI:16899


subject: CHEBI:229657

subject_name: Lotilaner

object_name: Demodex blepharitis


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Advanced Urothelial Carcinoma


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib


subject: CHEBI:173077


subject: UNII:I8309403R0

subject_name: Peginterferon beta-1a

object_name: kidney failure


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Acute Pain


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine


subject: UMLS:C4287651

object_name: tetanus


subject: UMLS:C4287651

object_name: HIV infection


subject: UMLS:C4287651

object_name: poliomyelitis


subject: UMLS:C4724850

subject_name: Lactobacillus reuteri Probiotic Tablet

object_name: Helicobacter pylori infection


subject: UMLS:C3886615

object_name: migraine


subject: UMLS:C3886615

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: prostate carcinoma


subject: CHEBI:6887

object_name: prostate cancer


subject: CHEBI:16919

subject_name: Creatine

object_name: Asthenia


subject: CHEBI:16919

object_name: Muscle spasm


subject: CHEBI:16919

object_name: Hypercholesterolemia


subject: CHEBI:16919

object_name: Ache


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: Chagas disease


subject: MESH:C540519

subject_name: PolyGlycoplex

object_name: Weight loss


subject: MESH:C540519

object_name: Weight Loss, CTCAE


subject: MESH:C540519

object_name: Appetite suppressed


subject: CHEBI:15552

subject_name: Epoprostenol


subject: CHEBI:15552


subject: CHEBI:15552


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: acute respiratory distress syndrome


subject: CHEBI:4466

object_name: adult acute respiratory distress syndrome


subject: CHEBI:4466

object_name: cytokine release syndrome


subject: CHEBI:4466

object_name: Cytokine storm


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: diabetes mellitus


subject: MESH:D009822

subject_name: Oils, Volatile

object_name: gingivitis


subject: MESH:D009822

object_name: Dental Plaque


subject: CHEBI:83630

subject_name: essential oil


subject: CHEBI:83630


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: Small cell lung cancer extensive stage


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Myofascial Trigger Point Pain


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: colon carcinoma


subject: UNII:Q46947FE7K

object_name: colorectal cancer


subject: UNII:Q46947FE7K

object_name: colon cancer


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:135449332

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:135449332

object_name: Myelodysplasia


subject: UniProtKB:Q14236

subject_name: EPAG_HUMAN Early lymphoid activation gene protein (sprot)


subject: UniProtKB:Q14236


subject: UniProtKB:Q14236


subject: PR:000007105

subject_name: early lymphoid activation gene protein


subject: PR:000007105


subject: PR:000007105


subject: UNII:G786V328X6

subject_name: Zatolmilast

object_name: Hepatic impairment


subject: UMLS:C3661202

object_name: Advanced Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3661202

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3661202

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3661202

object_name: Refractory Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3661202

object_name: Unresectable Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3661202

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C3661202

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C3661202

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C0013230

subject_name: Investigational New Drugs

object_name: Alzheimer disease type 1


subject: UMLS:C0013230

object_name: Alzheimer disease


subject: CHEBI:41139

subject_name: BETAINE

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:41139

object_name: Atypical Lipoma


subject: CHEBI:41139

object_name: well-differentiated liposarcoma


subject: CHEBI:41139

object_name: type 2 diabetes mellitus


subject: CHEBI:79068

subject_name: Crocin

object_name: osteoarthritis, knee


subject: CHEBI:8499

subject_name: Propranolol

object_name: COPD, severe early onset


subject: CHEBI:8499

object_name: chronic obstructive pulmonary disease


subject: UniProtKB:P23739

subject_name: SUIS_RAT Sucrase-isomaltase, intestinal (sprot)

object_name: Tracheal intubation morbidity


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib

object_name: metastatic neoplasm


subject: PUBCHEM.COMPOUND:78162481

object_name: Metastatic Lesion


subject: PUBCHEM.COMPOUND:78162481

object_name: Recurrent tumor


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Brenner tumor


subject: CHEBI:45863

object_name: ovarian undifferentiated adenocarcinoma


subject: CHEBI:45863

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:45863

object_name: ovarian serous cystadenocarcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: fallopian tube carcinoma


subject: UNII:5TAA004E22

object_name: fallopian tube cancer


subject: UNII:5TAA004E22

object_name: Ovarian cancer stage III


subject: UNII:5TAA004E22

object_name: peritoneum cancer


subject: UNII:5TAA004E22

object_name: ovarian seromucinous carcinoma


subject: UNII:5TAA004E22

object_name: ovarian Brenner tumor


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22

object_name: ovarian mucinous cystadenocarcinoma


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Mania, CTCAE


subject: CHEBI:25681

object_name: Mania


subject: CHEBI:40279

subject_name: Allopurinol

object_name: coronary artery disorder


subject: CHEBI:40279

object_name: coronary atherosclerosis


subject: CHEBI:40279

object_name: diabetes mellitus


subject: UNII:70U2NQU0FP

object_name: HIV infection


subject: UMLS:C2828312

subject_name: celgosivir hydrochloride


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: liver failure


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN


subject: PUBCHEM.COMPOUND:49865963

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Wrinkled face


subject: CHEBI:3160

object_name: Crow's feet


subject: UMLS:C5448053

object_name: chronic hepatitis B virus infection


subject: UMLS:C5448053

object_name: hepatitis B


subject: CHEBI:6129

subject_name: Ketorolac

object_name: type 2 diabetes mellitus


subject: UMLS:C1442791

subject_name: Chocolate antigen

object_name: Parkinson disease


subject: CHEMBL.COMPOUND:CHEMBL2108921

subject_name: CHOCOLATE


subject: UMLS:C2728194

subject_name: chocolate allergenic extract


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: CHEBI:132922

object_name: retinopathy of prematurity


subject: CHEBI:132922

object_name: exudative vitreoretinopathy 1


subject: CHEBI:132922

object_name: Retinopathy of Prematurity, AE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:23503

subject_name: DL-Cycloserine

object_name: opiate dependence


subject: CHEBI:40009

subject_name: Cycloserine


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: carcinoma of esophagus


subject: UNII:R8DG7T2D3A

object_name: esophageal cancer


subject: UNII:R8DG7T2D3A

object_name: Childhood Esophageal Carcinoma


subject: UNII:R8DG7T2D3A

object_name: neoplasm of esophagus


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: venous thromboembolism


subject: PUBCHEM.COMPOUND:52943456

object_name: thrombophilia due to thrombin defect


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: dehydration (Na, H2O)


subject: CHEBI:231673

object_name: Dehydration, CTCAE


subject: CHEBI:231673

object_name: Dehydration


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: PUBCHEM.COMPOUND:91820602


subject: CHEBI:9150

subject_name: Simvastatin

object_name: small cell lung carcinoma


subject: UMLS:C4763495

subject_name: Nimesulide-Hyaluronic Acid Conjugate CA102N

object_name: metastatic colorectal cancer


subject: CHEBI:63724

object_name: pancreatic neoplasm


subject: CHEBI:63724

object_name: exocrine pancreatic carcinoma


subject: CHEBI:63724

object_name: malignant pancreatic neoplasm


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Locally Advanced Skin Squamous Cell Carcinoma


subject: UMLS:C4053601


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C2917435

subject_name: Mood Stabilizer

object_name: endogenous depression


subject: UMLS:C2917435

object_name: major depressive disorder


subject: CHEBI:8707

subject_name: Quetiapine


subject: UMLS:C5222496

subject_name: Repository Corticotropin Injection

object_name: diabetic kidney disease


subject: UMLS:C2698851

subject_name: POMx

object_name: common cold


subject: CHEBI:8382

subject_name: Prednisone

object_name: Addison Disease


subject: CHEBI:8382

object_name: adrenocortical insufficiency


subject: CHEBI:51164

subject_name: Lisuride

object_name: cocaine abuse


subject: CHEBI:8494

subject_name: Propiverine hydrochloride

object_name: Urinary incontinence


subject: CHEBI:8494

object_name: Urinary Incontinence, CTCAE 5.0


subject: CHEBI:8493

subject_name: Propiverine


subject: CHEBI:8493


subject: CHEBI:82699

subject_name: Oritavancin

object_name: staphylococcal infection


subject: CHEBI:82699

object_name: Staphylococcal Skin Infections


subject: CHEBI:82699

object_name: streptococcal infection


subject: CHEBI:82699

object_name: Wounds and Injuries


subject: CHEBI:82699

object_name: cellulitis


subject: CHEBI:82699

object_name: cellulitis on exam (physical finding)


subject: CHEBI:82699

object_name: abscess


subject: CHEBI:64312

subject_name: Memantine

object_name: Central Nervous System Neoplasms, Primary


subject: CHEBI:64312

object_name: central nervous system cancer


subject: CHEBI:64312

object_name: Childhood Malignant Central Nervous System Neoplasm


subject: CHEBI:64312

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:6904

subject_name: Metoprolol

object_name: Childhood Breast Carcinoma


subject: CHEBI:6904

object_name: breast carcinoma


subject: CHEBI:6904

object_name: breast cancer


subject: UNII:2PEX5N7DQ4

subject_name: Fevipiprant

object_name: atopic eczema


subject: UMLS:C2954632

subject_name: TobraDex ST

object_name: blepharitis


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: colon carcinoma


subject: UMLS:C0499161

object_name: colorectal cancer


subject: UMLS:C0499161

object_name: colon cancer


subject: UNII:H6MSM69SSM

object_name: schizophrenia


subject: UNII:55L20667O4


subject: CHEBI:73272

subject_name: CANAGLIFLOZIN

object_name: pancreatic neoplasm


subject: CHEBI:73272

object_name: exocrine pancreatic carcinoma


subject: CHEBI:73272

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:74323022

subject_name: Canagliflozin


subject: PUBCHEM.COMPOUND:74323022


subject: PUBCHEM.COMPOUND:74323022


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: thyroid stimulating; hormone, C


subject: UNII:9B8NWP8K91

subject_name: VALILOXYBATE

object_name: Somnolence


subject: UNII:9B8NWP8K91

object_name: Parkinson disease


subject: UMLS:C5671083

subject_name: L-valine, 3-carboxypropyl ester


subject: UMLS:C5671083


subject: UNII:2N4O9L084N

subject_name: Nabilone

object_name: Nausea and vomiting


subject: UNII:U59UGK3IPC

subject_name: Ublituximab

object_name: follicular lymphoma


subject: UMLS:C2934225


subject: UNII:38073MQB2A

subject_name: Umbralisib


subject: UNII:38073MQB2A

object_name: marginal zone lymphoma


subject: UNII:38073MQB2A

object_name: MALT lymphoma


subject: CHEBI:135910

subject_name: Ganirelix

object_name: Irritable heart


subject: CHEBI:135910

object_name: neurocirculatory asthenia


subject: UMLS:C0872894

subject_name: ganirelix acetate


subject: UMLS:C0872894


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Friedreich ataxia


subject: CHEBI:8378

object_name: Friedreich ataxia 1


subject: CHEBI:8378

object_name: cardiomyopathy


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate

object_name: osteoarthritis, knee


subject: CHEBI:189965

subject_name: Prosapogenin

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:189965

object_name: Fatigue


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404


subject: UNII:Y180U02GSB

object_name: inherited lipid metabolism disorder


subject: UNII:Y180U02GSB

object_name: Dyslipidemia


subject: UNII:Y180U02GSB

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Malignant neoplasm of female breast


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:51098

subject_name: Motesanib

object_name: Childhood Neuroblastoma


subject: CHEBI:51098

object_name: neuroblastoma


subject: CHEMBL.COMPOUND:CHEMBL2107856

subject_name: IMETELSTAT


subject: CHEMBL.COMPOUND:CHEMBL2107856


subject: UNII:F60NE4XB53

subject_name: imetelstat


subject: UNII:F60NE4XB53


subject: UMLS:C1541591

subject_name: omburtamab I-131


subject: UMLS:C1541591


subject: UMLS:C1541591

object_name: neoplastic meningitis


subject: UMLS:C1541591

object_name: CNS metastases


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: coronary artery disorder


subject: UMLS:C0720099

subject_name: Duration brand of oxymetazoline


subject: UMLS:C1170584

subject_name: Restasis

object_name: Epiphora


subject: PUBCHEM.COMPOUND:3384

subject_name: Fluoromethalone


subject: UMLS:C1564840

subject_name: FML Forte


subject: CHEBI:31625

subject_name: Fluorometholone


subject: MESH:D065346

subject_name: Lubricant Eye Drops


subject: UMLS:C2608262


subject: UMLS:C1815286

subject_name: Refresh Endura


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: neuromyelitis optica


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Metastatic Cutaneous Melanoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4305


subject: CHEBI:4305

object_name: metastatic melanoma


subject: UMLS:C0021735

subject_name: Viraferon


subject: UMLS:C0021735


subject: UMLS:C0021735


subject: PUBCHEM.COMPOUND:16683012

subject_name: Sodium stibogluconate


subject: PUBCHEM.COMPOUND:16683012


subject: PUBCHEM.COMPOUND:16683012


subject: PUBCHEM.COMPOUND:16683013

subject_name: Stibogluconate


subject: PUBCHEM.COMPOUND:16683013


subject: PUBCHEM.COMPOUND:16683013


subject: CHEBI:28148


subject: CHEBI:28148


subject: CHEBI:28148


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: UMLS:C0879283

object_name: adult lymphoma


subject: UMLS:C0879283

object_name: lymphoma


subject: UMLS:C0879283

object_name: pediatric lymphoma


subject: UMLS:C0879283

object_name: leukemia


subject: UMLS:C0879283

object_name: childhood leukemia


subject: CHEBI:135515

subject_name: Bendamustine


subject: CHEBI:135515


subject: CHEBI:62932

subject_name: mycophenolate


subject: CHEBI:62932


subject: CHEBI:62932


subject: CHEBI:62932


subject: CHEBI:62932


subject: CHEBI:9241

subject_name: Spironolactone

object_name: cardiovascular disorder


subject: CHEBI:50695

subject_name: monobactam

object_name: cephalosporin allergy


subject: CHEBI:50695

object_name: Cephalosporin adverse reaction


subject: CHEBI:50695

object_name: Allergy to antibiotic


subject: CHEBI:50695

object_name: drug allergy


subject: CHEBI:50695

object_name: drug pseudoallergy


subject: CHEBI:50695

object_name: History of - drug allergy


subject: CHEBI:50695

object_name: Drug-induced anaphylaxis


subject: CHEBI:50695

object_name: Beta lactam adverse reaction


subject: CHEBI:27933

subject_name: beta-lactam antibiotic


subject: CHEBI:27933


subject: CHEBI:27933


subject: CHEBI:27933


subject: CHEBI:27933


subject: CHEBI:27933


subject: CHEBI:27933


subject: CHEBI:27933


subject: CHEBI:474053

subject_name: Cefazolin


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:474053


subject: CHEBI:3515

subject_name: Cefuroxime


subject: CHEBI:3515


subject: CHEBI:3515


subject: CHEBI:3515


subject: CHEBI:3515


subject: CHEBI:3515


subject: CHEBI:3515


subject: CHEBI:3515


subject: CHEBI:204928

subject_name: Cefotaxime


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:204928


subject: CHEBI:3509


subject: CHEBI:3509


subject: CHEBI:3509


subject: CHEBI:3509


subject: CHEBI:3509


subject: CHEBI:3509


subject: CHEBI:3509


subject: CHEBI:3509


subject: PUBCHEM.COMPOUND:6321415

subject_name: ceftazidime


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: PUBCHEM.COMPOUND:6321415


subject: CHEBI:29007

subject_name: Ceftriaxone


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:29007


subject: CHEBI:478164

subject_name: Cefepime


subject: CHEBI:478164


subject: CHEBI:478164


subject: CHEBI:478164


subject: CHEBI:478164


subject: CHEBI:478164


subject: CHEBI:478164


subject: CHEBI:478164


subject: UMLS:C0733486

subject_name: Pre-Pen


subject: UMLS:C0733486


subject: UMLS:C0733486


subject: UMLS:C0733486


subject: UMLS:C0733486


subject: UMLS:C0733486


subject: UMLS:C0733486


subject: UMLS:C0733486


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate


subject: CHEBI:179553


subject: CHEBI:179553


subject: CHEBI:179553


subject: CHEBI:179553


subject: CHEBI:179553


subject: CHEBI:179553


subject: CHEBI:179553


subject: CHEBI:51354

subject_name: Picibanil


subject: CHEBI:51354


subject: CHEBI:51354


subject: CHEBI:51354


subject: CHEBI:51354


subject: CHEBI:51354


subject: CHEBI:51354


subject: CHEBI:51354


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:17334


subject: CHEBI:17334


subject: CHEBI:17334


subject: CHEBI:17334


subject: CHEBI:17334


subject: CHEBI:17334


subject: CHEBI:17334


subject: UMLS:C2095775

subject_name: ampicillins


subject: UMLS:C2095775


subject: UMLS:C2095775


subject: UMLS:C2095775


subject: UMLS:C2095775


subject: UMLS:C2095775


subject: UMLS:C2095775


subject: UMLS:C2095775


subject: CHEBI:28971

subject_name: Ampicillin


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:28971


subject: CHEBI:3535

subject_name: Cephalexin


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3535


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: UNII:69K7K19H4L

subject_name: CEFACLOR


subject: UNII:69K7K19H4L


subject: UNII:69K7K19H4L


subject: UNII:69K7K19H4L


subject: UNII:69K7K19H4L


subject: UNII:69K7K19H4L


subject: UNII:69K7K19H4L


subject: UNII:69K7K19H4L


subject: PUBCHEM.COMPOUND:2609

subject_name: cefaclor


subject: PUBCHEM.COMPOUND:2609


subject: PUBCHEM.COMPOUND:2609


subject: PUBCHEM.COMPOUND:2609


subject: PUBCHEM.COMPOUND:2609


subject: PUBCHEM.COMPOUND:2609


subject: PUBCHEM.COMPOUND:2609


subject: PUBCHEM.COMPOUND:2609


subject: CHEBI:53667

subject_name: Cefadroxil


subject: CHEBI:53667


subject: CHEBI:53667


subject: CHEBI:53667


subject: CHEBI:53667


subject: CHEBI:53667


subject: CHEBI:53667


subject: CHEBI:53667


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: PUBCHEM.COMPOUND:520990


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3479


subject: CHEBI:3504

subject_name: Cefpodoxime


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3504


subject: CHEBI:3485

subject_name: Cefdinir


subject: CHEBI:3485


subject: CHEBI:3485


subject: CHEBI:3485


subject: CHEBI:3485


subject: CHEBI:3485


subject: CHEBI:3485


subject: CHEBI:3485


subject: UNII:97I1C92E55

subject_name: CEFIXIME


subject: UNII:97I1C92E55


subject: UNII:97I1C92E55


subject: UNII:97I1C92E55


subject: UNII:97I1C92E55


subject: UNII:97I1C92E55


subject: UNII:97I1C92E55


subject: UNII:97I1C92E55


subject: CHEBI:472657

subject_name: Cefixime


subject: CHEBI:472657


subject: CHEBI:472657


subject: CHEBI:472657


subject: CHEBI:472657


subject: CHEBI:472657


subject: CHEBI:472657


subject: CHEBI:472657


subject: UMLS:C1384659

object_name: thyroid tumor


subject: UMLS:C1384659

object_name: thyroid gland carcinoma


subject: UMLS:C1384659

object_name: thyroid cancer


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: CHEBI:49960


subject: UMLS:C5555467

subject_name: Latozinemab

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UMLS:C5555467

object_name: amyotrophic lateral sclerosis


subject: UMLS:C5705654


subject: UMLS:C5705654


subject: CHEBI:32060

subject_name: propagermanium


subject: CHEMBL.COMPOUND:CHEMBL2107883

subject_name: REPAGERMANIUM


subject: UNII:1Q2P9TO9Q7

subject_name: Propagermanium


subject: UMLS:C2733644

subject_name: Black Seed Oil

object_name: type 2 diabetes mellitus


subject: UMLS:C4085968

subject_name: cabiralizumab

object_name: tenosynovial giant cell tumor


subject: UMLS:C4085968

object_name: tenosynovial giant cell tumor, diffuse type


subject: UMLS:C5447486

subject_name: Tamgiblimab

object_name: Advanced lung cancer


subject: UNII:11Z5AIU653

subject_name: simtuzumab

object_name: hepatitis C


subject: UNII:11Z5AIU653

object_name: Liver Fibrosis


subject: UNII:11Z5AIU653

object_name: HIV infection


subject: CHEMBL.COMPOUND:CHEMBL2109667

subject_name: SIMTUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109667


subject: CHEMBL.COMPOUND:CHEMBL2109667


subject: UMLS:C2984523


subject: UMLS:C2984523


subject: UMLS:C2984523


subject: UMLS:C4727207

subject_name: Nidanilimab

object_name: melanoma


subject: UMLS:C4727207

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4727207

object_name: urothelial carcinoma


subject: UMLS:C4727207

object_name: transitional cell carcinoma


subject: UMLS:C4727207

object_name: non-small cell lung carcinoma


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:35366

subject_name: fatty acid

object_name: cardiovascular disorder


subject: UMLS:C0003234

subject_name: Anthracycline Antibiotics

object_name: triple-negative breast carcinoma


subject: CHEBI:48120

subject_name: anthracycline


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Primary mediastinal large B-cell lymphoma stage II


subject: UNII:7XL5ISS668

object_name: Primary mediastinal large B-cell lymphoma stage IV


subject: UNII:7XL5ISS668

object_name: Primary mediastinal large B-cell lymphoma stage I


subject: UNII:7XL5ISS668

object_name: Primary mediastinal large B-cell lymphoma stage III


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:85994

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:85994

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:85994

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:85994

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:75179

subject_name: Trifluridine

object_name: colorectal neoplasm


subject: CHEBI:90879

subject_name: Tipiracil


subject: UMLS:C5417792

subject_name: MC1R Agonist MT-7117

object_name: cutaneous porphyria


subject: UMLS:C5417792

object_name: erythropoietic protoporphyria


subject: UMLS:C5417792

object_name: autosomal erythropoietic protoporphyria


subject: UMLS:C5417792

object_name: protoporphyria, erythropoietic, 1


subject: UMLS:C5417792

object_name: X-linked lymphoproliferative disease due to SH2D1A deficiency


subject: UMLS:C5417792

object_name: X-linked lymphoproliferative syndrome


subject: UMLS:C5417792

object_name: X-linked erythropoietic protoporphyria


subject: CHEBI:5899

subject_name: indinavir sulfate

object_name: HIV infection


subject: CHEBI:44032

subject_name: Indinavir


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: respiratory failure


subject: PUBCHEM.COMPOUND:22976653

object_name: acute respiratory failure


subject: PUBCHEM.COMPOUND:22976653

object_name: thrombophilia


subject: PUBCHEM.COMPOUND:22976653

object_name: Fibrinolysis Shutdown


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: PR:000012825


subject: PR:000012825


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: myocardial infarction


subject: PUBCHEM.COMPOUND:53477758

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:53477758

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: nevoid basal cell carcinoma syndrome


subject: UMLS:C2830069

object_name: basal cell carcinoma


subject: UMLS:C2830069

object_name: skin basal cell carcinoma


subject: CHEBI:90863

subject_name: Sonidegib


subject: UNII:889I657R9P

subject_name: Desmethylsibutramine

object_name: Overweight


subject: UNII:987R943R3P

subject_name: Didesmethylsibutramine


subject: CHEBI:9137

subject_name: Sibutramine


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: aortic valve disease 2


subject: CHEBI:73604

object_name: aortic stenosis


subject: CHEBI:73604

object_name: aortic valve disease 3


subject: CHEBI:73604

object_name: Stenosis of aorta


subject: CHEBI:73604

object_name: Systemic inflammatory response


subject: CHEBI:30356

subject_name: isobutyl group

object_name: Acute Pain


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: Cognitive impairment


subject: CHEBI:367163

subject_name: Darunavir


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: CHEBI:184662


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: hypoglycemia


subject: CHEMBL.COMPOUND:CHEMBL5314341

object_name: Blood glucose below reference range (finding)


subject: CHEMBL.COMPOUND:CHEMBL5314341

object_name: Hypoglycemia, CTCAE


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:31348

object_name: Pancreatic carcinoma stage III


subject: CHEBI:31348

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:69VKY8P7EA

object_name: pancreatic adenocarcinoma


subject: UMLS:C2700458

subject_name: Dovitinib Lactate


subject: UMLS:C0003921

subject_name: artificial tears (medication)

object_name: glaucoma


subject: UMLS:C0003921

object_name: Glaucoma, CTCAE


subject: UMLS:C2608262

subject_name: Lubricant Eye Drops


subject: UMLS:C2608262


subject: UMLS:C3853661

subject_name: Artificial Tears


subject: UMLS:C3853661


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129